Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,138.00p
   
  • Change Today:
    -7.00p
  • 52 Week High: 1,181.00p
  • 52 Week Low: 576.50p
  • Currency: UK Pounds
  • Shares Issued: 124.77m
  • Volume: 1,014
  • Market Cap: £1,419.88m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
Chairman: David E. Wheadon
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Daniel A. Ninivaggi
Independent Non-Executive Director: Keith Humphreys
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Tony Kingsley
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Peter Bains
Independent Non-Executive Director: Joe Ciaffoni
Senior Independent Director: Juliet Thompson
Non-Executive Dir:

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:INDVL
ISIN: GB00BN4HT335

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,138.00p
Change Today -7.00p
% Change -0.61 %
52 Week High 1,181.00p
52 Week Low 576.50p
Volume 1,014
Shares Issued 124.77m
Market Cap £1,419.88m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.03% below the market average55.03% below the market average55.03% below the market average55.03% below the market average55.03% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average68.43% above the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income Not Available
Growth
51.93% above the market average51.93% above the market average51.93% above the market average51.93% above the market average51.93% above the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 08-Jul-2025

Time Volume / Share Price
08:46 7 @ 1,139.50p
08:37 53 @ 1,138.00p
08:37 60 @ 1,138.00p
08:37 31 @ 1,138.00p
08:37 35 @ 1,139.00p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page